DanielRobertDefranciscoMD

Addiction

Physician

Dr. Defrancisco is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Office
10 Nathan D Perlman Place
Bernstein Pavilion, 2nd Floor
New York, NY 10003
Phone+1 212-844-1437
Is this information wrong?

Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Psychiatry, 2015 - 2019
Drexel University College of MedicineClass of 2015
University of ColoradoFellowship, Addiction Psychiatry

PubMed

2 citations
Cannabis use is associated with low plasma endocannabinoid Anandamide in individuals with psychosis.
Anahita Bassir Nia, Claire L Gibson, Sharron A Spriggs, Samantha E Jankowski, Daniel DeFrancisco, Amy Swift, Charles Perkel, Igor Galynker, Chandrashekhar Honrao, Alex...> ;Journal of Psychopharmacology. 2023 May 1
6 citations
Cannabinoid use in psychotic patients impacts inflammatory levels and their association with psychosis severity.
Claire L. Gibson, Anahita Bassir Nia, Sharron Spriggs, Daniel DeFrancisco, Amy Swift, Charles Perkel, Xiaobo Zhong, Madhu Mazumdar, Nicolas F. Fernandez, Manishkumar P...> ;Psychiatry Research. 2020 Nov 1
9 citations
The Relevance of Sex in the Association of Synthetic Cannabinoid Use With Psychosis and Agitation in an Inpatient Population.
Anahita Bassir Nia, Claire L. Mann, Sharron Spriggs, Daniel DeFrancisco, Steven Carbonaro, Lyla Parvez, Igor Galynker, Charles Perkel, Yasmin L. Hurd> ;The Journal of Clinical Psychiatry. 2019 Jul 2